Inhalant used for inhibiting coronavirus, and preparation method and application of inhalant
A coronavirus and inhalant technology, applied in the field of coronavirus-inhibiting inhalants and their preparation, can solve the problems of low target organ selectivity and narrow therapeutic window for systemic drug administration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0060] 10mg remdesivir dry powder inhalation.
[0061] Take 10g of remdesivir micropowder, put it into No. 3 hard capsules, 10mg per capsule, 1000 capsules in total.
Embodiment 2
[0063] 1mg remdesivir dry powder inhalation.
[0064] Put 1g of remdesivir micropowder and 19g of lactose into the Turbula T2F mixer for mixing, evenly distribute it into No. 3 capsules, 20mg per capsule.
[0065] Table 1. Prescription volume
[0066] components Dosage per capsule Dosage for 1000 capsules Remdesivir 1mg 1g lactose 19mg 19g
Embodiment 3
[0068] 0.5mg remdesivir dry powder inhalation.
[0069] Put 0.5g of remdesivir micropowder and 19.5g of lactose into the Turbula T2F mixer for mixing, and evenly distribute them into No. 3 capsules, each 20mg.
[0070] Table 2. Prescription volume
[0071] components Dosage per capsule Dosage for 1000 capsules Remdesivir 0.5mg 0.5g lactose 19.5mg 19.5g
PUM
Property | Measurement | Unit |
---|---|---|
The average particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
The average particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com